Author

Uday Kumar Kolkundkar

Observed name: Uday K. Kolkundkar

Institution: Stempeutics (India)

Observed institutions: Stempeutics (India), Manipal Hospital

ORCID: 0000-0001-5235-0828

Observed ORCID: 0000-0001-5235-0828

OpenAlex ID: A5011231543

Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs

2024 · Suresh Kannan, S. Gokul Krishna, et al. · Scientific Reports · 44

Characteristics of Pooled Wharton’s Jelly Mesenchymal Stromal Cells (WJ-MSCs) and their Potential Role in Rheumatoid Arthritis Treatment

2022 · Suresh Kannan, Pachaiyappan Viswanathan, et al. · Stem Cell Reviews and Reports · 23

Exosome Therapy: A Promising Avenue for Treating Intervertebral Disc Degeneration

2025 · Shreya Bhat, Suresh Kannan, et al. · Tissue Engineering and Regenerative Medicine · 12

A First of its kind Phase II clinical trial in critical limb ischemia patients using bone marrow derived, pooled, allogeneic mesenchymal stromal cells (Stempeucel®)

2015 · Anish S. Majumdar, Sudha Balasubramanian, et al. · Cytotherapy · 3

Mesenchymal Stromal Cell-Derived Secretome for Diabetic Foot Ulcers: Therapeutic Potential, Challenges in Clinical Translation, and Future Directions

2026 · Neema V Shetty, Suresh Kannan, et al. · Tissue Engineering and Regenerative Medicine

Works count: 5

Citation count: 82

H-index: 3

I10-index: 3